Ng, Cheng Han http://orcid.org/0000-0002-8297-1569
Tan, Darren Jun Hao
Nistala, Kameswara Rishi Yeshayahu
Syn, Nicholas
Xiao, Jieling
Tan, Eunice Xiang Xuan
Woo, Felicia Zuying
Chew, Nicholas W. S.
Huang, Daniel Q.
Dan, Yock Young
Sanyal, Arun J.
Muthiah, Mark D. http://orcid.org/0000-0002-9724-4743
Article History
Received: 4 May 2021
Accepted: 6 August 2021
First Online: 21 August 2021
Declarations
:
: Arun J. Sanyal: Dr Sanyal is President of Sanyal Biotechnology and has stock options in Genfit, Akarna, Tiziana, Indalo, Durect and Galmed. He has served as a consultant to Astra Zeneca, Nitto Denko, Enyo, Ardelyx, Conatus, Nimbus, Amarin, Salix, Tobira, Takeda, Jannsen, Gilead, Terns, Birdrock, Merck, Valeant, BoehringerâIngelheim, Lilly, Hemoshear, Zafgen, Novartis, Novo Nordisk, Pfizer, Exhalenz and Genfit. He has been an unpaid consultant to Intercept, Echosens, Immuron, Galectin, Fractyl, Syntlogic, Affimune, Chemomab, Zydus, Nordic Bioscience, Albireo, Prosciento, Surrozen and Bristol Myers Squibb. His institution has received grant support from Gilead, Salix, Tobira, Bristol Myers, Shire, Intercept, Merck, Astra Zeneca, Malinckrodt, Cumberland and Novartis. He receives royalties from Elsevier and UptoDate. Remaining authors have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.